Key result
Modifiable youth risk factors associate with preclinical markers of cardiovascular disease in adulthood, and amending these trajectories can reduce markers to levels seen in unexposed individuals.
Why the study?
Does modifying cardiovascular risk factors in youth prevent the development of preclinical markers of cardiovascular disease in adulthood?
Does modifying cardiovascular risk factors in youth prevent the development of preclinical markers of cardiovascular disease in adulthood?
Modifying cardiovascular risk factors during youth and the transition to adulthood can prevent or reverse the development of preclinical markers of cardiovascular disease.
PURPOSE OF REVIEW: To detail recent developments linking modifiable youth risk factors with preclinical markers of cardiovascular disease such as carotid artery intima-media thickness, pulse-wave velocity (PVW) and large artery stiffness, brachial artery flow-mediated dilatation, left ventricular geometry, and coronary artery calcification in adulthood. RECENT FINDINGS: Population-based data from prospective cohort studies beginning in youth with follow-up into adulthood have shown that the modifiable youth risk factors of elevated blood lipids, blood pressure, and adiposity, smoking (active and passive), metabolic disorders, physical inactivity, low cardiorespiratory fitness, and diet associate with preclinical markers of cardiovascular disease in adulthood. The data suggest that, in some instances, those who amend their trajectory by not maintaining these risk factors into adulthood experience reductions in preclinical markers to levels associated with never having had the risk factor. SUMMARY: Though avoidance of risk factors in youth is ideal, there is still a window for intervention where long-lasting cardiovascular effects might be avoided. Health-enhancing changes in the rates of active and passive smoking, adiposity, increased physical activity, accentuated fitness, modified diet, and socioeconomic position in the transition from youth to adulthood might be important in modifying an individual's trajectory from high risk in youth to low risk in adulthood.
No takes yet. Share an insight, caveat, or question.
Magnussen et al. (2013) conducted a review in Cardiovascular disease. Modifiable youth risk factors vs. Absence of risk factors was evaluated on Preclinical markers of cardiovascular disease in adulthood. Modifiable youth risk factors associate with preclinical markers of cardiovascular disease in adulthood, and amending these trajectories can reduce markers to levels seen in unexposed individuals.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: